The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people

BACKGROUND: Children and young people (CYP) with juvenile idiopathic arthritis (JIA) are known to have impaired health-related quality of life (HRQoL), which is improved significantly for many by treatment with methotrexate (MTX). However, a significant proportion of CYP experience difficulties in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulligan, Kathleen, Wedderburn, Lucy R, Newman, Stanton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676858/
https://www.ncbi.nlm.nih.gov/pubmed/26653415
http://dx.doi.org/10.1186/s12969-015-0052-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676858/
https://www.ncbi.nlm.nih.gov/pubmed/26653415
http://dx.doi.org/10.1186/s12969-015-0052-6

Ejemplares similares